CAPSONI, Simona
 Distribuzione geografica
Continente #
NA - Nord America 9.020
AS - Asia 4.309
EU - Europa 2.034
SA - Sud America 666
AF - Africa 114
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 2
Totale 16.165
Nazione #
US - Stati Uniti d'America 8.884
SG - Singapore 1.683
CN - Cina 867
BR - Brasile 517
IT - Italia 483
VN - Vietnam 447
HK - Hong Kong 368
TR - Turchia 301
DE - Germania 272
UA - Ucraina 261
GB - Regno Unito 214
PL - Polonia 184
BD - Bangladesh 143
SE - Svezia 140
JP - Giappone 137
FR - Francia 131
FI - Finlandia 119
RU - Federazione Russa 105
IN - India 98
MX - Messico 71
ID - Indonesia 65
CA - Canada 50
AR - Argentina 48
IQ - Iraq 45
ZA - Sudafrica 45
NL - Olanda 30
EC - Ecuador 25
PH - Filippine 22
CO - Colombia 20
AU - Australia 18
ES - Italia 18
VE - Venezuela 17
PK - Pakistan 16
UZ - Uzbekistan 15
MY - Malesia 14
TN - Tunisia 13
AT - Austria 12
KR - Corea 12
MA - Marocco 12
CL - Cile 11
KE - Kenya 11
SA - Arabia Saudita 11
PY - Paraguay 9
CZ - Repubblica Ceca 8
LT - Lituania 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
AZ - Azerbaigian 6
BO - Bolivia 6
CH - Svizzera 6
EG - Egitto 6
KZ - Kazakistan 6
SD - Sudan 6
UY - Uruguay 6
BE - Belgio 5
DZ - Algeria 5
IE - Irlanda 5
IL - Israele 5
IR - Iran 5
NP - Nepal 4
OM - Oman 4
PE - Perù 4
TH - Thailandia 4
BG - Bulgaria 3
GY - Guiana 3
JM - Giamaica 3
JO - Giordania 3
PS - Palestinian Territory 3
PT - Portogallo 3
RO - Romania 3
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LY - Libia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
TW - Taiwan 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EU - Europa 1
GD - Grenada 1
GH - Ghana 1
HN - Honduras 1
Totale 16.144
Città #
Ashburn 1.060
Singapore 967
Fairfield 899
Woodbridge 794
Houston 602
San Jose 554
Ann Arbor 436
Chandler 418
Jacksonville 404
Hong Kong 361
Seattle 352
Santa Clara 341
Cambridge 301
Beijing 293
Wilmington 291
Warsaw 182
Izmir 171
Ho Chi Minh City 151
Tokyo 132
Los Angeles 125
Milan 113
Hanoi 108
Nanjing 108
Council Bluffs 104
Princeton 98
Boardman 96
Lauterbourg 96
Dallas 95
New York 88
San Diego 73
The Dalles 60
Ferrara 50
Jakarta 50
São Paulo 46
Dearborn 45
Chicago 44
Rome 44
Addison 41
Nanchang 41
Munich 39
Falls Church 38
Columbus 37
London 34
Mexico City 34
Boydton 31
Orem 31
Phoenix 30
Brooklyn 28
Shenyang 27
Hebei 26
Moscow 26
Shanghai 26
Denver 24
Des Moines 24
Tianjin 24
Chennai 23
Helsinki 23
Jiaxing 23
Atlanta 21
Mountain View 21
Rio de Janeiro 21
Haiphong 20
Johannesburg 20
San Francisco 20
Stockholm 20
Changsha 19
Bursa 17
Da Nang 17
Redwood City 17
Boston 16
Baghdad 15
Manchester 15
Mumbai 15
Nuremberg 15
Montreal 14
Turin 14
Norwalk 13
Toronto 13
Buffalo 12
New Delhi 12
Belo Horizonte 11
Dong Ket 11
Guangzhou 11
Kunming 11
Poplar 11
Hefei 10
Perth 10
Tashkent 10
Cape Town 9
Frankfurt am Main 9
Medellín 9
Quito 9
Amsterdam 8
Ankara 8
Cincinnati 8
Lahore 8
Lanzhou 8
Secaucus 8
Tappahannock 8
Turku 8
Totale 11.334
Nome #
NGF steers microglia toward a neuroprotective phenotype 329
Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen and skeletal muscle dystrophy 312
Environmental enrichment delays the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 241
Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis 227
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 227
Alzheimer-like neurodegeneration in aged antinerve Growth factor transgenic mice 225
Non-human transgenic animals for the study of neurodegenerative syndromes 224
A small molecule targeting the multifactorial nature of Alzheimer's disease 222
Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice 220
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 217
Dark rearing blocks the developmental down-regulation of brain-derived neurotrophic factor messenger RNA expression in layers IV and V of the rat visual cortex 217
A dual mechanism linking NGF/ProNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 215
Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus 213
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 213
Understanding pain perception through genetic painlessness diseases: The role of NGF and proNGF 207
A carnivore species (Canis familiaris) expresses circadian melatonin rhythm in the peripheral blood and melatonin receptors in the brain 206
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity 203
2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist 198
ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 192
Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice 191
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: Mining of microarray data by logic classification and feature selection 188
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 186
Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies 183
Neutralization of Nerve Growth Factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 182
ProNGF drives localized and cell selective parvalbumin interneuron and perineuronal net depletion in the dentate gyrus of transgenic mice 180
Electrophysiological and behavioral effect of ozone on mice olfactory bulb 180
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 177
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease 175
Pathogen-Free Husbandry Conditions Alleviate Behavioral Deficits and Neurodegeneration in AD10 Anti-NGF Mice. 172
Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration 171
Intranasal "painless" human nerve growth factors slows amyloid neurodegeneration and prevents memory deficits in app x PS1 mice 171
SorLA Deficiency Dissects Amyloid Pathology from Tau and Cholinergic Neurodegeneration in a Mouse Model of Alzheimer's Disease 170
Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities 169
Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE 166
A Microglial Function for the Nerve Growth Factor: Predictions of the Unpredictable 165
Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models 165
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 165
Cholinergic striatal neurons are increased in HSAN V homozygous mice despite reduced NGF bioavailability 165
Intranasal delivery of therapeutic proteins for neurological diseases 164
Postnatal development of GFAP in mouse visual cortex is not affected by light deprivation 163
The positional identity of mouse ES cell-generated neurons is affected by BMP signaling 160
Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation 160
Antagonization of NGF in adult mice by transgenic antibodies causes progressive learning and memory impairments 159
Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice 159
Development of a non invasive NGF-based therapy for Alzheimer's disease 158
Nerve growth factor regulates axial rotation during early stages of chick embryo development 156
Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice 156
Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice 154
In vitro receptor binding properties of a "painless" NGF mutein, linked to hereditary sensory autonomic neuropathy type V 154
Characterization of endothelinA receptors in cerebral and peripheral arteries of the rat 154
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding 154
Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons 152
Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody 152
Towards non invasive nerve growth factor therapies for Alzheimer's disease 152
Rat visual cortical neurones express TrkA NGF receptor 151
Reduction of regional cerebral blood flow by melatonin in young rats 151
Differential regulation of brain-derived neurotrophic factor messenger RNA cellular expression in the adult rat visual cortex 149
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 148
In the adult hippocampus, chronic nerve growth factor deprivation shifts GABAergic signaling from the hyperpolarizing to the depolarizing direction 147
Painless Nerve Growth Factor: A TrkA biased agonist mediating a broad neuroprotection via its actions on microglia cells 146
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 145
Melatonin signal transduction and mechanism of action in the central nervous system: Using the rabbit cortex as a model 144
Endogenous A beta causes cell death via early tau hyperphosphorylation 143
Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice 143
Mismatch between BDNF mRNA and protein expression in the developing visual cortex: the role of visual experience 142
Pathogen free conditions slow the onset of neurodegeneration in a mouse model of nerve growth factor deprivation 142
From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V 140
Muscular dystrophy in adult and aged anti-NGF transgenic mice resembles an inclusion body myopathy 139
Graphene Promotes Axon Elongation through Local Stall of Nerve Growth Factor Signaling Endosomes 135
Distribution and characterization of the melatonin receptors in the hypothalamus and pituitary gland of three domestic ungulates 134
Characterization by Gene Expression Analysis of Two Groups of Dopaminergic Cells Isolated from the Mouse Olfactory Bulb 134
Long-term memantine treatment prevents behavioral deficits in a mouse model of sporadic Alzheimer's disease 131
Non-human transgenic animals for the study of neurodegenerative syndromes 130
The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model 130
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 128
A p75 neurotrophin receptor‐sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microglia 126
Nerve Growth Factor regulates astrocyte physiology in vivo 124
Rescue of the neurodegenerative phenotype in AD11 anti-NGF mice 123
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 121
Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis 121
Interaction between NH2-tau fragment and Aß in AD mitochondria contributes to the synaptic deterioration 119
Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction 119
INIBITORE DI TNF ALPHA ASTROCITARIO PER L’USO NEL TRATTAMENTO DI MALATTIE NEUROLOGICHE 119
Distribution and pharmacological characterization of melatonin receptors in the brain of the Japanese quail (Coturnix japonica) 112
Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity 111
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 110
Muteins of hNGF, therapeutic uses and pharmaceutical compositions 108
Vasoactive intestinal peptide-like immunoreactive fibers in the pineal gland of the sheep 106
Nerve Growth Factor Neutralization Promotes Oligodendrogenesis by Increasing miR-219a-5p Levels 104
Unraveling the Role of Dopaminergic and Calretinin Interneurons in the Olfactory Bulb 104
null 100
Expression of the melatonin receptor in Xenopus laevis: A comparative study between protein and mRNA distribution 100
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve growth factor mice 97
Inhibitor of astrocyte TNF alpha for use in the treatment of neurological diseases 94
Enteric Alpha-Synuclein Inclusions, Colonic Inflammation, Increased Mucosal Permeability and Alterations of Bowel Neuromuscular Functions Precede Central Neurodegeneration in a Transgenic Mouse Model of Parkinson's Disease 94
Role and Characterization of Dopaminergic Interneurons in Mouse Olfactory Bulbs 92
null 89
Reversal of neurological deficits by painless nerve growth factor in a mouse model of Rett syndrome 88
Getting Into the Brain: The Intranasal Approach to Enhance the Delivery of Nerve Growth Factor and Its Painless Derivative in Alzheimer’s Disease and Down Syndrome 85
Taking pain out of NGF: a "painless" NGF mutant with full neurotrophic activity 84
Totale 15.738
Categoria #
all - tutte 73.685
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.685


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202191 0 0 0 0 0 0 0 0 0 0 0 91
2021/2022954 48 119 84 33 39 40 61 62 31 81 84 272
2022/20231.036 141 60 12 134 158 124 121 86 123 9 50 18
2023/2024471 53 66 19 20 24 41 10 31 3 32 16 156
2024/20252.158 28 52 171 67 271 167 73 168 314 265 368 214
2025/20266.046 480 296 590 700 797 310 902 307 555 657 297 155
Totale 16.409